Hospicecare In The Berkshires 877 South Street, Suite 1w, Pittsfield, MA, 01201 | |
(413) 443-2994 |
News Archive
Researchers at Columbia University's Mailman School of Public Health assessed the geographical distribution of the long-term burden of Post-Traumatic Stress Disorder in a region of Liberia and report that the prevalence of PTSD remains high nearly two decades after the principal conflict there and five years after war in Liberia ended entirely.
Researchers at UAB (University of Alabama at Birmingham) have new information on the structure of a key enzyme in bacteria that could lead to improved antibiotics and less antibiotic resistance.
In a new study available on the preprint server bioRxiv*, a multinational research group demonstrated how monoclonal antibodies strongly inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro at even sub-nanomolar concentrations. This makes them a prime candidate for the treatment of coronavirus disease (COVID-19).
New research published in the April issue of The Journal of Nuclear Medicine reveals that systemic inflammation causes an increase in depressive symptoms and metabolic changes in the parts of the brain responsible for mood and motivation. With this finding, researchers can begin to test potential treatments for depression for patients that experience symptoms that are related to inflammation in the body or within the brain.
› Verified 7 days ago
Name | Hospicecare In The Berkshires |
---|---|
Location | 877 South Street, Suite 1w, Pittsfield, Massachusetts |
Hospice ID | 221531 |
Category | Freestanding Hospice |
Ownership Type | Voluntary Non-profit - Private |
Profit Type | NON-PROFIT |
Accreditation Provider | Community Health Accreditation Partner (CHAP) |
SSA county code | 010 |
News Archive
Researchers at Columbia University's Mailman School of Public Health assessed the geographical distribution of the long-term burden of Post-Traumatic Stress Disorder in a region of Liberia and report that the prevalence of PTSD remains high nearly two decades after the principal conflict there and five years after war in Liberia ended entirely.
Researchers at UAB (University of Alabama at Birmingham) have new information on the structure of a key enzyme in bacteria that could lead to improved antibiotics and less antibiotic resistance.
In a new study available on the preprint server bioRxiv*, a multinational research group demonstrated how monoclonal antibodies strongly inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro at even sub-nanomolar concentrations. This makes them a prime candidate for the treatment of coronavirus disease (COVID-19).
New research published in the April issue of The Journal of Nuclear Medicine reveals that systemic inflammation causes an increase in depressive symptoms and metabolic changes in the parts of the brain responsible for mood and motivation. With this finding, researchers can begin to test potential treatments for depression for patients that experience symptoms that are related to inflammation in the body or within the brain.
› Verified 7 days ago
NPI Number | 1457358533 |
Organization Name | Hospicecare In The Berkshires, Inc. |
Address | 877 South St Pittsfield, Massachusetts, 01201 |
Phone Number | (413)443-2994 |
News Archive
Researchers at Columbia University's Mailman School of Public Health assessed the geographical distribution of the long-term burden of Post-Traumatic Stress Disorder in a region of Liberia and report that the prevalence of PTSD remains high nearly two decades after the principal conflict there and five years after war in Liberia ended entirely.
Researchers at UAB (University of Alabama at Birmingham) have new information on the structure of a key enzyme in bacteria that could lead to improved antibiotics and less antibiotic resistance.
In a new study available on the preprint server bioRxiv*, a multinational research group demonstrated how monoclonal antibodies strongly inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro at even sub-nanomolar concentrations. This makes them a prime candidate for the treatment of coronavirus disease (COVID-19).
New research published in the April issue of The Journal of Nuclear Medicine reveals that systemic inflammation causes an increase in depressive symptoms and metabolic changes in the parts of the brain responsible for mood and motivation. With this finding, researchers can begin to test potential treatments for depression for patients that experience symptoms that are related to inflammation in the body or within the brain.
› Verified 7 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.8 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 99.1 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 93.7 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 69.2 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 99.8 | 97.3 |
Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 98.9 | 93.3 |
News Archive
Researchers at Columbia University's Mailman School of Public Health assessed the geographical distribution of the long-term burden of Post-Traumatic Stress Disorder in a region of Liberia and report that the prevalence of PTSD remains high nearly two decades after the principal conflict there and five years after war in Liberia ended entirely.
Researchers at UAB (University of Alabama at Birmingham) have new information on the structure of a key enzyme in bacteria that could lead to improved antibiotics and less antibiotic resistance.
In a new study available on the preprint server bioRxiv*, a multinational research group demonstrated how monoclonal antibodies strongly inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro at even sub-nanomolar concentrations. This makes them a prime candidate for the treatment of coronavirus disease (COVID-19).
New research published in the April issue of The Journal of Nuclear Medicine reveals that systemic inflammation causes an increase in depressive symptoms and metabolic changes in the parts of the brain responsible for mood and motivation. With this finding, researchers can begin to test potential treatments for depression for patients that experience symptoms that are related to inflammation in the body or within the brain.
› Verified 7 days ago
Home Health Aides | 7 |
Counselors | 1.5 |
Homemakers | 0.6 |
Licensed Practical or Vocational Nurses | 0.4 |
Medical Social Workers | 3.5 |
Physicians | 0.88 |
Registered Nurses | 17.85 |
Other Personnel | 15.88 |
Total Employees | 47.61 |
---|
News Archive
Researchers at Columbia University's Mailman School of Public Health assessed the geographical distribution of the long-term burden of Post-Traumatic Stress Disorder in a region of Liberia and report that the prevalence of PTSD remains high nearly two decades after the principal conflict there and five years after war in Liberia ended entirely.
Researchers at UAB (University of Alabama at Birmingham) have new information on the structure of a key enzyme in bacteria that could lead to improved antibiotics and less antibiotic resistance.
In a new study available on the preprint server bioRxiv*, a multinational research group demonstrated how monoclonal antibodies strongly inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro at even sub-nanomolar concentrations. This makes them a prime candidate for the treatment of coronavirus disease (COVID-19).
New research published in the April issue of The Journal of Nuclear Medicine reveals that systemic inflammation causes an increase in depressive symptoms and metabolic changes in the parts of the brain responsible for mood and motivation. With this finding, researchers can begin to test potential treatments for depression for patients that experience symptoms that are related to inflammation in the body or within the brain.
› Verified 7 days ago
Others | 5.3 |
Total Volunteers | 5.3 |
---|
News Archive
Researchers at Columbia University's Mailman School of Public Health assessed the geographical distribution of the long-term burden of Post-Traumatic Stress Disorder in a region of Liberia and report that the prevalence of PTSD remains high nearly two decades after the principal conflict there and five years after war in Liberia ended entirely.
Researchers at UAB (University of Alabama at Birmingham) have new information on the structure of a key enzyme in bacteria that could lead to improved antibiotics and less antibiotic resistance.
In a new study available on the preprint server bioRxiv*, a multinational research group demonstrated how monoclonal antibodies strongly inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro at even sub-nanomolar concentrations. This makes them a prime candidate for the treatment of coronavirus disease (COVID-19).
New research published in the April issue of The Journal of Nuclear Medicine reveals that systemic inflammation causes an increase in depressive symptoms and metabolic changes in the parts of the brain responsible for mood and motivation. With this finding, researchers can begin to test potential treatments for depression for patients that experience symptoms that are related to inflammation in the body or within the brain.
› Verified 7 days ago
Hospicecare In The Berkshires Location: 877 South Street, Suite 1w, Pittsfield, Massachusetts, 01201 Phone: (413) 443-2994 |